EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease

Manasee Gedam, Hui Zheng

European Journal of Immunology · 2024-08 · 54 (8)

DOI: 10.1002/eji.202350815 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, online erschienen am 22.05.2024. Verfasst von Manasee Gedam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Human Genetics, Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Signal Transduction, Receptors, Complement. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia among the elderly population. Despite its widespread prevalence, our comprehension of the intricate mechanisms governing the pathogenesis of the disease remains incomplete, posing a challenge for the development of efficient therapies. Pathologically characterized by the presence of amyloid β plaques and neurofibrillary tau tangles, AD is also accompanied by the hyperactivation of glial cells and the immune system. The complement cascade, the evolutionarily conserved innate immune pathway, has emerged as a significant contributor to AD. This review focuses on one of the complement components, the C3a receptor (C3aR), covering its structure, ligand‐receptor interaction, intracellular signaling and its functional consequences. Drawing insights from cellular and AD mouse model studies, we present the multifaceted role of complement C3aR signaling in AD and attempt to convey to the readers that C3aR acts as a crucial immune and metabolic modulator to influence AD pathogenesis. Building on this framework, the objective of this review is to inform future research endeavors and facilitate the development of therapeutic strategies for this challenging condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseSignal TransductionReceptors, ComplementHumansAnimalsMiceImmunity, InnateDisease Models, Animal

Stichwörter der Autor:innen

Alzheimer's diseaseC3aRComplement pathwayHIF‐1Microglia

Substanzen

Receptors, Complementcomplement C3a receptor

Autor:innen und Institutionen

  • Department of Molecular and Human Genetics, Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA.

Förderung

  • NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institutes of Health

Zitieren

APA

Gedam, M., & Zheng, H. (2024). Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease. European Journal of Immunology, 54(8). https://doi.org/10.1002/eji.202350815

Vancouver

Gedam M, Zheng H. Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease. European Journal of Immunology. 2024;54(8). doi:10.1002/eji.202350815

BibTeX
@article{Gedam2024,
  author = {Gedam, Manasee and Zheng, Hui},
  title = {Complement C3aR signaling: Immune and metabolic modulation and its impact on Alzheimer's disease},
  journal = {European Journal of Immunology},
  year = {2024},
  volume = {54},
  number = {8},
  doi = {10.1002/eji.202350815}
}
Kostenlos starten →